<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">zabmedvestnik</journal-id><journal-title-group><journal-title xml:lang="ru">Забайкальский медицинский вестник</journal-title><trans-title-group xml:lang="en"><trans-title>Transbaikalian Medical Bulletin</trans-title></trans-title-group></journal-title-group><issn pub-type="epub">1998-6173</issn><publisher><publisher-name>Читинская государственная медицинская академия</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.52485/19986173_2022_2_64</article-id><article-id custom-type="elpub" pub-id-type="custom">zabmedvestnik-158</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>НАУЧНЫЕ ОБЗОРЫ</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>SCIENTIFIC REVIEWS</subject></subj-group></article-categories><title-group><article-title>ХАРАКТЕРИСТИКА ПОРАЖЕНИЯ МИОКАРДА ПРИ COVID - 19 У ДЕТЕЙ: ОТДАЛЕННЫЕ ПОСЛЕДСТВИЯ, ПОДХОДЫ К РЕАБИЛИТАЦИИ</article-title><trans-title-group xml:lang="en"><trans-title>CHARACTERISTICS OF MYOCARDIAL DAMAGE DURING COVID-19 IN CHILDREN: REMOTE CONSEQUENCES, REHABILITATION APPROACHES</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Опарина</surname><given-names>А. Г.</given-names></name><name name-style="western" xml:lang="en"><surname>Oparina</surname><given-names>A. G.</given-names></name></name-alternatives><bio xml:lang="ru"><p>672000, Чита, ул. Горького, 39а</p></bio><bio xml:lang="en"><p>39A Gorky str., Chita, Russia, 672000</p></bio><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Долина</surname><given-names>А Б.</given-names></name><name name-style="western" xml:lang="en"><surname>Dolina</surname><given-names>A. B.</given-names></name></name-alternatives><bio xml:lang="ru"><p>672000, Чита, ул. Горького, 39а</p></bio><bio xml:lang="en"><p>39A Gorky str., Chita, Russia, 672000</p></bio><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Богомолова</surname><given-names>И. К.</given-names></name><name name-style="western" xml:lang="en"><surname>Bogomolova</surname><given-names>I. K.</given-names></name></name-alternatives><bio xml:lang="ru"><p>672000, Чита, ул. Горького, 39а</p></bio><bio xml:lang="en"><p>39A Gorky str., Chita, Russia, 672000</p></bio><xref ref-type="aff" rid="aff-1"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>Федеральное государственное бюджетное образовательное учреждение высшего образования «Читинская государственная медицинская академия» Минздрава России</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Chita State Medical Academy</institution><country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2022</year></pub-date><pub-date pub-type="epub"><day>05</day><month>08</month><year>2024</year></pub-date><volume>0</volume><issue>2</issue><fpage>64</fpage><lpage>78</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Опарина А.Г., Долина А.Б., Богомолова И.К., 2024</copyright-statement><copyright-year>2024</copyright-year><copyright-holder xml:lang="ru">Опарина А.Г., Долина А.Б., Богомолова И.К.</copyright-holder><copyright-holder xml:lang="en">Oparina A.G., Dolina A.B., Bogomolova I.K.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://www.zabmedvestnik.ru/jour/article/view/158">https://www.zabmedvestnik.ru/jour/article/view/158</self-uri><abstract><p>Учитывая имеющиеся знания о поражении сердца при новой коронавирусной инфекции у детей, остается множество пробелов и уязвимых мест, которые могут послужить возникновению новых проблем или обострению старых. Поскольку заболевание относительно молодое, требуется еще много времени для полноценного изучения его характеристик. Осложнения со стороны сердечно-сосудистой системы у детей дают возможность задуматься о влиянии на дальнейшее развитие детского организма. Мировое врачебное сообщество на данном этапе развития заболевания собирает приобретенный опыт воедино и способствует в разработке новых методов лечения и реабилитации.</p></abstract><trans-abstract xml:lang="en"><p>Taking into account the existing knowledge about heart damage in the case of a new coronavirus infection in children, there are many gaps and vulnerabilities that can cause new problems or exacerbate old ones. Since the disease is relatively young, it takes a lot of time to fully study its characteristics.</p><p>Complications from the cardiovascular system in children give an opportunity to think about the impact on the further development of the child's body. The world medical community at this stage of the development of the disease gathers the acquired experience together and contributes to the development of new methods of treatment and rehabilitation.</p></trans-abstract><kwd-group xml:lang="ru"><kwd>SARS-CoV-2</kwd><kwd>COVID-19</kwd><kwd>сердечно-сосудистые осложнения</kwd><kwd>дети</kwd><kwd>реабилитация</kwd></kwd-group><kwd-group xml:lang="en"><kwd>SARS-CoV-2</kwd><kwd>COVID-19</kwd><kwd>cardiovascular complications</kwd><kwd>children</kwd><kwd>rehabilitation</kwd></kwd-group><funding-group><funding-statement xml:lang="ru">Финансирование данной работы не проводилось</funding-statement></funding-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Chang L.Y., Lu C.Y., Chao P.L. Viral infection associated with Kawasaki disease. Journal of the Formosan Medical Association. 2014. 113 (3). 148-154. DOI: 10.1016/j.jfma.2013.12.008.</mixed-citation><mixed-citation xml:lang="en">Chang L.Y., Lu C.Y., Chao P.L. Viral infection associated with Kawasaki disease. Journal of the Formosan Medical Association. 2014. 113 (3). 148–154. DOI: 10.1016/j.jfma.2013.12.008.</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Намазова-Баранова Л.С., Баранов А.А. COVID-19 и дети. Пульмонология. 2020. 30(5). 609-628. DOI: 10.18093/0869-0189-2020-30-5-609-628.</mixed-citation><mixed-citation xml:lang="en">Namazova-Baranova L.S., Baranov A.A. COVID-19 and children. Pul'monologiya. 2020. 30 (5). 609–628. DOI: 10.18093/0869-0189-2020-30-5-609-628. In Russian.</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Meo S.A., Alhowikan A.M., Al-khlaiwi T., Meo I.M., Halepoto D.M., Iqbal M., Usmani A.M., Hajjar W., Ahmed N. Novel coronavirus 2019-nCoV: prevalence, biological and clinical characteristics comparison with SARS-CoV and MERS-CoV. European Review for Medical and Pharmacological Sciences. 2020. 24(4). 2012-2019. DOI: 10.26355/eurrev_202002_20379.</mixed-citation><mixed-citation xml:lang="en">Meo S.A., Alhowikan A.M., Al-khlaiwi T., Meo I.M., Halepoto D.M., Iqbal M., Usmani A.M., Hajjar W., Ahmed N. Novel coronavirus 2019-nCoV: prevalence, biological and clinical characteristics comparison with SARS-CoV and MERS-CoV. European Review for Medical and Pharmacological Sciences. 2020. 24 (4). 2012-2019. DOI: 10.26355/eurrev_202002_20379.</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Щелканов М.Ю., Попова А.Ю., Дедков В.Г., Акимкин В.Г., Малеев В.В. История изучения и современная классификация коронавирусов. Инфекция и иммунитет. 2020. 10(2). 221-246. DOI: 10.15789/2220-7619-HOI-1412</mixed-citation><mixed-citation xml:lang="en">Shchelkanov M.Yu., Popova A.Yu., Dedkov V.G., Akimkin V.G., Maleev V.V. History of the study and modern classification of coronaviruses. Infektsiya i immunitet. 2020. vol. 10. no. 2. 221–246. In Russian.</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Lai C.C., Shih T.P., Ko W.C., Tang H.J., Hsueh P.R. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and coronavirus disease-2019 (COVID-19): the epidemic and the challenges. Int. J. Antimicrob. Agents. 2020. 55(3). 105924. DOI: 10.1016/j.ijantimicag.2020.105924.</mixed-citation><mixed-citation xml:lang="en">Lai C.C., Shih T.P., Ko W.C., Tang H.J., Hsueh P.R. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and coronavirus disease-2019 (COVID-19): the epidemic and the challenges. Int.J. Antimicrob. Agents. 2020. DOI: 10.1016/j.ijantimicag.2020.105924.</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Gorbalenya A.E. Severe acute respiratory syndrome-related coronavirus – The species and its viruses, a statement of the Coronavirus Study Group. Nature Microbiology. 2020. № 2. DOI: 10.1038/s41564-020-0695-з.</mixed-citation><mixed-citation xml:lang="en">Gorbalenya A.E. Severe acute respiratory syndrome-related coronavirus — The species and its viruses, a statement of the Coronavirus Study Group. Nature Microbiology. 2020. № 2. DOI: 10.1038/s41564-020-0695- з.</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">COVID-19 Dashboard by the Center for Systems Science and Engineering (CSSE) at Johns Hopkins University (JHU). Available from: https://coronavirus.jhu.edu/map.html.</mixed-citation><mixed-citation xml:lang="en">COVID-19 Dashboard by the Center for Systems Science and Engineering (CSSE) at Johns Hopkins University (JHU). Available from: https://coronavirus.jhu.edu/map.html.</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Becker R.C. COVID-19 update: Covid-19-associated coagulopathy. Journal of Thrombosis and Thrombolysis. 2020. 50. 54-67.</mixed-citation><mixed-citation xml:lang="en">Becker R.C. COVID-19 update: Covid-19-associated coagulopathy. Journal of Thrombosis and Thrombolysis. 2020. 50. 54–67.</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Libby P., Luscher T. COVID-19 is, in the end, an endothelial disease. European Heart Journal. 2020. 41. 3038-3044.</mixed-citation><mixed-citation xml:lang="en">Libby P., Luscher T. COVID-19 is, in the end, an endothelial disease. European Heart Journal. 2020. 41. 3038–3044.</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Абакушина Е.В. Иммунологические аспекты коронавирусной болезни, вызванной SARS- COV-2. Гены &amp; Клетки. 2020. XV(3). 14-21. DOI: 10.23868/202011002.</mixed-citation><mixed-citation xml:lang="en">Abakushina E.V. Immunological aspects of coronavirus disease caused by SARS-COV-2. Meditsinskiy radiologicheskiy nauchnyy tsentr im. A.F. Tsyba. Geny &amp; Kletki. Tom XV №3. 2020. DOI: 10.23868/202011002. In Russian.</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Pons S., Fodil S., Azoulay E., Zafrani L. The vascular endothelium: the cornerstone of organ dysfunction in severe SARS-CoV-2 infection. Critical Care Medicine. 2020. 24. 353.</mixed-citation><mixed-citation xml:lang="en">Pons S., Fodil S., Azoulay E., Zafrani L. The vascular endothelium: the cornerstone of organ dysfunction in severe SARS-CoV-2 infection. Critical Care Medicine. 2020.24. 353.</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Черняго Т.Ю., Фомина В.С., Федык О.В., Яшкин М.Н. Методы оценки функционального состояния эндотелия у пациентов с варикозной болезнью вен нижних конечностей: перспективы лечебной тактики. Вестник национального медико-хирургического центра имени Н.И. Пирогова. 2021. 16(1). 145-150. DOI: 10.25881/BPNMSC.2021.17.48.028.</mixed-citation><mixed-citation xml:lang="en">Chernyago T.Yu., Fomina V.S., Fedyk O.V., Yashkin M.N. Methods for assessing the functional state of the endothelium in patients with varicose veins of the lower extremities: prospects of therapeutic tactics. Vestnik natsional'nogo mediko-khirurgicheskogo tsentra imeni N.I. Pirogova. 2021.16(1).145–150. DOI: 10.25881/BPNMSC.2021.17.48.028. In Russian.</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Mishra A.K., Sahu K.K., George A.A., Lal A. A review of cardiac manifestations and predictors of outcome in patients with COVID-19. Heart &amp; Lung. 2020. 49(6). 848-852. DOI: 10.1016/j.hrtlng.2020.04.019.</mixed-citation><mixed-citation xml:lang="en">Mishra A. K., Sahu K. K., George A. A., Lal A. A review of cardiac manifestations and predictors of outcome in patients with COVID–19. Heart &amp; Lung. 49. 848. DOI:1016/j.hrtlng.2020.04.019.2020.</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Guo T., Fan Y., Chen M. Cardiovascular Implications of Fatal outcomes of patients with coronavirus disease 2019 (COVID-19). JAMA Cardiol. 2020. 5(7). 811-818. DOI: 10.1001/jamacardio.2020.1017.</mixed-citation><mixed-citation xml:lang="en">Guo T., Fan Y., Chen M. Cardiovascular Implications of Fatal outcomes of patients with coronavirus disease 2019 (COVID-19). JAMA Cardiol. 2020. 5(7). 811-818. DOI: 10.1001/jamacardio.2020.1017.</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Lindner D., Fitzek A., Bräuninger H. Association of Cardiac Infection With SARS-CoV-2 in Confirmed COVID-19 Autopsy Cases. JAMA Cardiol. 2020. 5(11). 1281-1285. DOI: 10.1001/jamacardio.2020.3551.</mixed-citation><mixed-citation xml:lang="en">Lindner D., Fitzek A., Bräuninger H. Association of Cardiac Infection With SARS-CoV-2 in Confirmed COVID-19 Autopsy Cases. JAMA Cardiol. 2020. 5 (11). 1281-1285. DOI: 10.1001/jamacardio.2020.3551.</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">Dennis A., Wamil M., Kapur S., Alberts J., Oben J., Cuthbertson D.J., Wootton D., Crooks M., Gabbay M., Brady M., Hishmeh L., Attree E., Heightman M., Banerjee R., Banerjee A. Multiorgan impairment in low-risk individuals with post-COVID-19 syndrome: a prospective, community-based study. MedRxiv. 2021. 11(3). e048391. DOI: 10.1136/bmjopen-2020-048391.</mixed-citation><mixed-citation xml:lang="en">Dennis A., Wamil M., Kapur S., Alberts J., Oben J., Cuthbertson D.J., Wootton D., Crooks M., Gabbay M., Brady M., Hishmeh L., Attree E., Heightman M., Banerjee R., Banerjee A. Multiorgan impairment in low-risk individuals with post-COVID-19 syndrome: a prospective, community-based study. MedRxiv. 2021. 11(3). e048391. DOI: 10.1136/bmjopen-2020-048391.</mixed-citation></citation-alternatives></ref><ref id="cit17"><label>17</label><citation-alternatives><mixed-citation xml:lang="ru">Ayoubkhani D., Khunti K., Nafilyan V., Maddox T., Humberstone B., Diamond I., Banerjee A. Post-covid syndrome in individuals admitted to hospital with covid-19: retrospective cohort study. medRxiv. 2021. 372. n693. DOI: 10.1136/bmj.n693.</mixed-citation><mixed-citation xml:lang="en">Ayoubkhani D., Khunti K., Nafilyan V., Maddox T., Humberstone B., Diamond I., Banerjee A. Post-covid syndrome in individuals admitted to hospital with covid-19: retrospective cohort study. medRxiv. 2021. 372. n693. DOI: 10.1136/bmj.n693.</mixed-citation></citation-alternatives></ref><ref id="cit18"><label>18</label><citation-alternatives><mixed-citation xml:lang="ru">Ackermann M., Verleden S.E., Kuehnel M., Haverich A., Welte T., Laenger F., Vanstapel A., Werlein C., Stark H., Tzankov A., Li W.W., Li V.W., Mentzer S.J., Jonigk D. Pulmonary vascular endothelialitis, thrombosis, and angiogenesis in Covid-19. The New England Journal of Medicine. 2020. 383(2). 120-128. DOI: 10.1056/NEJMoa2015432.</mixed-citation><mixed-citation xml:lang="en">Ackermann, M. et al. Pulmonary vascular endothelialitis, thrombosis, and angiogenesis in Covid-19. The New England Journal of Medicine. 2020. 383 (2). 120-128. DOI: 10.1056/NEJMoa2015432.</mixed-citation></citation-alternatives></ref><ref id="cit19"><label>19</label><citation-alternatives><mixed-citation xml:lang="ru">Teuwen L.A., Geldhof V., Pasut A., Carmeliet P. COVID-19: the vasculature unleashed. Nature Reviews Immunology. 2020. 20(7). 389-391. DOI: 10.1038/s41577-020-0343-0.</mixed-citation><mixed-citation xml:lang="en">Teuwen L.A., Geldhof V., Pasut A., Carmeliet P. COVID-19: the vasculature unleashed. Nature Reviews Immunology. 2020. 20(7). 389-391. DOI: 10.1038/s41577-020-0343-0.</mixed-citation></citation-alternatives></ref><ref id="cit20"><label>20</label><citation-alternatives><mixed-citation xml:lang="ru">Lu X., Zhang L., Du H., Zhang J., Li Y., Qu J., Zhang W., Wang Y., Bao S., Li Y., Wu C., Liu H., Liu D., Shao J., Peng X., Yang Y., Liu Z., Xiang Y., Zhang F., Silva R.M., Pinkerton K.E., Shen K., Xiao H., Xu S., Wong G.W.K. SARS-CoV-2 Infection in Children. The New England Journal of Мedicine. 2020. 382 (17). 1663-1665. DOI: 10.1056/NEJMc2005073/.</mixed-citation><mixed-citation xml:lang="en">Lu X., Zhang L., Du H., Zhang J., Li Y., Qu J., Zhang W., Wang Y., Bao S., Li Y., Wu C., Liu H., Liu D., Shao J., Peng X., Yang Y., Liu Z., Xiang Y., Zhang F., Silva R.M., Pinkerton K.E., Shen K., Xiao H., Xu S., Wong G.W.K.. SARS-CoV-2 Infection in Children. The New England Journal of Мedicine. 2020. 382 (17). 1663–1665. DOI: 10.1056/NEJMc2005073/</mixed-citation></citation-alternatives></ref><ref id="cit21"><label>21</label><citation-alternatives><mixed-citation xml:lang="ru">Paediatric Intensive Care Society. PICS Statement regarding novel presentation of multi- system inflammatory disease. Available from: https://pccsociety.uk/news/pics-statement-regarding-novel-presentation-of-multisystem-inflammatory-disease.</mixed-citation><mixed-citation xml:lang="en">Paediatric Intensive Care Society. PICS Statement regarding novel presentation of multi- system inflammatory disease. Available from: https://pccsociety.uk/news/pics-statement-regarding-novel-presentation-of-multisystem-inflammatory-disease.</mixed-citation></citation-alternatives></ref><ref id="cit22"><label>22</label><citation-alternatives><mixed-citation xml:lang="ru">Pinto B.G.G., Oliveira A.E.R., Singh Y., Jimenez L., Gonçalves A.N.A., Ogava R.L.T., Creighton R., Peron J.P.S. ACE2 Expression is Increased in the Lungs of Patients with Comorbidities Associated with Severe COVID-19. The Journal of Infectious Diseases. 2020. DOI: 10.1093/infdis/jiaa332.</mixed-citation><mixed-citation xml:lang="en">Bruna G.G. Pinto, Antonio E.R. Oliveira, Youvika Singh, Leandro Jimenez, Andre N.A. Gonçalves, Rodrigo L.T. Ogava, Rachel Creighton, Jean Pierre Schatzmann Peron. ACE2 Expression is Increased in the Lungs of Patients with Comorbidities Associated with Severe COVID-19.The Journal of Infectious Diseases. 2020. DOI: 10.1093/infdis/jiaa332.</mixed-citation></citation-alternatives></ref><ref id="cit23"><label>23</label><citation-alternatives><mixed-citation xml:lang="ru">Иванов О.Б., Бухвальд Е.М. Национальная безопасность России: новые проблемы и новые приоритеты. Этап: экономическая теория, анализ, практика. 2021. Available from: https://cyberleninka.ru/article/n/natsionalnaya-bezopasnost-rossii-novye-problemy-i-novye- prioritety/viewer</mixed-citation><mixed-citation xml:lang="en">Ivanov O.B., Bukhval'd E.M. National Security of Russia: new challenges and new priorities. Etap: ekonomicheskaya teoriya, analiz, praktika. 2021. Available from: https://cyberleninka.ru/article/n/natsionalnaya-bezopasnost-rossii-novye-problemy-i-novye-prioritety/viewer. In Russian.</mixed-citation></citation-alternatives></ref><ref id="cit24"><label>24</label><citation-alternatives><mixed-citation xml:lang="ru">Медицинская реабилитация при новой коронавирусной инфекции (COVID-19). Временные методические рекомендации (утв. Минздравом России). Версия 2 (31.07.2020). Available from: https://static-minzdrav.gov.ru/system/attachments/attaches/000/051/187/original/31072020_Reab_COVID-19_v1.pdf.</mixed-citation><mixed-citation xml:lang="en">Medical rehabilitation for new coronavirus infection (COVID-19). Vremennye metodicheskie rekomendatsii (utv. Minzdravom Rossii).Versiya 2 (31.07.2020). Available from: https://static- minzdrav.gov.ru/system/attachments/attaches/000/051/187/original/31072020_Reab_COVID-19_v1.pdf. In Russian.</mixed-citation></citation-alternatives></ref><ref id="cit25"><label>25</label><citation-alternatives><mixed-citation xml:lang="ru">Колесникова Н.В., Кондратьева Е.И., Нестерова И.В., Гаприндашвили Е.Г., Пономаренко Ю.Б., Асекретова Т.В., Чудилова Г.А., Ломтатидзе Л.В. Возрастные и половые особенности некоторых цитокинов крови здоровых детей. Кубанский научный медицинский вестник 2011. 6(129). 68-72.</mixed-citation><mixed-citation xml:lang="en">Kolesnikova N.V., Kondrat'eva E.I., Nesterova I.V., Gaprindashvili E.G., Ponomarenko Yu.B., Asekretova T.V., Chudilova G.A., Lomtatidze L.V. Age and sex characteristics of some cytokines in the blood of healthy children. Kubanskiy nauchnyy meditsinskiy vestnik № 6 (129). 2011. In Russian.</mixed-citation></citation-alternatives></ref><ref id="cit26"><label>26</label><citation-alternatives><mixed-citation xml:lang="ru">Козлов И.А., Тюрин И.Н. Сердечно-сосудистые осложнения COVID-19. Вестник анестезиологии и реаниматологии. 2020. 17(4). 14-22. DOI: 10.21292/2078-5658-2020-17-4-14-22.</mixed-citation><mixed-citation xml:lang="en">Kozlov I.A., Tyurin I.N. Cardiovascular complications of COVID-19.Vestnik anesteziologii i reanimatologii. Tom 17. № 4. С. 14-22. 2020. DOI: 10.21292/2078-5658-2020-17-4-14-22. In Russian.</mixed-citation></citation-alternatives></ref><ref id="cit27"><label>27</label><citation-alternatives><mixed-citation xml:lang="ru">Бойцов С.А. Грипп, новая коронавирусная инфекция и сердечно-сосудистые заболевания. Кардиологический вестник. 2021. 16(1). 5-9. DOI: 10.17116/Cardiobulletin2021160115.</mixed-citation><mixed-citation xml:lang="en">Boytsov S.A. Influenza, new coronavirus infection and cardiovascular diseases. Kardiologicheskiy vestnik. 2021. 16(1). 5–9. DOI: 10.17116/Cardiobulletin2021160115. In Russian.</mixed-citation></citation-alternatives></ref><ref id="cit28"><label>28</label><citation-alternatives><mixed-citation xml:lang="ru">Миокардит у детей. Клинические рекомендации (Утверждены Союзом педиатров России). 2016 г. Available from: https://www.pediatr-russia.ru/information/klin-rek/deystvuyushchie-klinicheskie-rekomendatsii/Миокардит%20дети%20СПР.v2.pdf.</mixed-citation><mixed-citation xml:lang="en">Myocarditis in children. (Approved by the Union of Pediatricians of Russia). Klinicheskie rekomendatsii. 2016 г. Available from: https://www.pediatr-russia.ru/information/klin-rek/deystvuyushchie-klinicheskie-rekomendatsii/Миокардит%20дети%20СПР.v2.pdf. In Russian.</mixed-citation></citation-alternatives></ref><ref id="cit29"><label>29</label><citation-alternatives><mixed-citation xml:lang="ru">Riphagen S., Gomez X., Gonzalez-Martinez C., Wilkinson N., Theocharis P. Hyperinflammatory shock in children during COVID-19 pandemic. Lancet. 2020. 395 (10237). 1607-1608. DOI: 10.1016/S0140-6736(20)31094-1.</mixed-citation><mixed-citation xml:lang="en">Riphagen S., Gomez X., Gonzalez-Martinez C., Wilkinson N., Theocharis P. Hyperinflammatory shock in children during COVID-19 pandemic. Lancet. 2020. 395 (10237). 1607–1608. DOI: 10.1016/S0140-6736(20)31094-1.</mixed-citation></citation-alternatives></ref><ref id="cit30"><label>30</label><citation-alternatives><mixed-citation xml:lang="ru">Ramcharan T., Nolan O., Lai C.Y., Prabhu N., Krishnamurthy R., Richter A.G., Jyothish D., Kanthimathinathan H.K., Welch S.B., Hackett S., Al-Abadi E., Scholefield B.R., Chikermane A. Paediatric Inflammatory Multisystem Syndrome: Temporally Associated with SARS-CoV-2 (PIMS-TS): Cardiac Features, Management and Short-Term Outcomes at a UK Tertiary Paediatric Hospital. Pediatric Cardiology. 2020. 41(7). 1391-1401. DOI: 10.1007/s00246-020-02391-2.</mixed-citation><mixed-citation xml:lang="en">Ramcharan T., Nolan O., Lai C.Y., Prabhu N., Krishnamurthy R., Richter A.G., Jyothish D., Kanthimathinathan H.K., Welch S.B., Hackett S., Al-Abadi E., Scholefield B.R., Chikermane A. Paediatric Inflammatory Multisystem Syndrome: Temporally Associated with SARS-CoV-2 (PIMS-TS): Cardiac Features, Management and Short-Term Outcomes at a UK Tertiary Paediatric Hospital. Pediatric Cardiology. 2020. 41(7). 1391-1401. DOI: 10.1007/s00246-020-02391-2.</mixed-citation></citation-alternatives></ref><ref id="cit31"><label>31</label><citation-alternatives><mixed-citation xml:lang="ru">Дегтярёва Е.А. COVID-19, постковидный синдром и детское сердце. StatusPraesens. 2021. 4(82)12. 53.</mixed-citation><mixed-citation xml:lang="en">Degtyareva E.A. COVID-19, postcovid syndrome and children's heart. StatusPraesens №4 (82) 12. 2021. С 53. In Russian.</mixed-citation></citation-alternatives></ref><ref id="cit32"><label>32</label><citation-alternatives><mixed-citation xml:lang="ru">Long Covid: what is it, and what is needed? London: Royal Society. 23 October 2020. Available from: https://royalsociety.org/blog/2021/02/what-do-we-know-about-long-covid/</mixed-citation><mixed-citation xml:lang="en">Long Covid: what is it, and what is needed? London: Royal Society. 23 October 2020.</mixed-citation></citation-alternatives></ref><ref id="cit33"><label>33</label><citation-alternatives><mixed-citation xml:lang="ru">Dennis A., Wamil M., Kapur S., Alberts J., Badley A.D., Decker G.A., Rizza C.A., Banerjee R., Banerjee A. Multi-organ impairment in low-risk individuals with long COVID. BMJ Open. 2021. 11 (3). e048391. DOI: 10.1136/bmjopen-2020-048391.</mixed-citation><mixed-citation xml:lang="en">Dennis A., Wamil M., Kapur S., Alberts J., Badley A.D., Decker G.A., Rizza C.A., Banerjee R., Banerjee A.. Multi-organ impairment in low-risk individuals with long COVID. BMJ Open. 2021. 11 (3). e048391. DOI: 10.1136/bmjopen-2020-048391.</mixed-citation></citation-alternatives></ref><ref id="cit34"><label>34</label><citation-alternatives><mixed-citation xml:lang="ru">WHO. A clinical case definition of post COVID-19 condition by a Delphi consensus: World Health Organization. 2021. Available from: https://covid19.who.int/, accessed 6 October 2021.</mixed-citation><mixed-citation xml:lang="en">WHO. A clinical case definition of post COVID-19 condition by a Delphi consensus: World Health Organization. 2021. Available from: https://covid19.who.int/, accessed 6 October 2021.</mixed-citation></citation-alternatives></ref><ref id="cit35"><label>35</label><citation-alternatives><mixed-citation xml:lang="ru">American Heart Association. "Heart function recovered quickly in children with COVID-19- related MIS-C condition." ScienceDaily. ScienceDaily. 19 January 2022. Available from: https://www.sciencedaily.com/releases/2022/01/220119090859.htm.</mixed-citation><mixed-citation xml:lang="en">American Heart Association. "Heart function recovered quickly in children with COVID-19- related MIS-C condition." ScienceDaily. ScienceDaily. 19 January 2022. Available from: https://www.sciencedaily.com/releases/2022/01/220119090859.htm</mixed-citation></citation-alternatives></ref><ref id="cit36"><label>36</label><citation-alternatives><mixed-citation xml:lang="ru">Медицинская реабилитация при новой коронавирусной инфекции (COVID-19). Временные методические рекомендации (утв. Минздравом России). Версия 1 (21.05.2020). Available from: https://static-0.minzdrav.gov.ru/system/attachments/attaches/000/051/187/original/31072020_Reab_COVID-19_v1.pdf.</mixed-citation><mixed-citation xml:lang="en">Medical rehabilitation in case of a new coronavirus infection (COVID-19). Vremennye metodicheskie rekomendatsii (utv. Minzdravom Rossii). Versiya 1 (21.05.2020). Available from: https://static-0.minzdrav.gov.ru/system/attachments/attaches/000/051/187/original/31072020_Reab_COVID-19_v1.pdf.</mixed-citation></citation-alternatives></ref><ref id="cit37"><label>37</label><citation-alternatives><mixed-citation xml:lang="ru">Хроническая сердечная недостаточность у детей. Клинические рекомендации. (Утверждены Союзом педиатров России). 2016 г. Available from: https://www.pediatr- russia.ru/information/klin-rek/deystvuyushchie-klinicheskie-rekomendatsii/ХСН%20дети%20СПР.v1.pdf.</mixed-citation><mixed-citation xml:lang="en">Chronic heart failure in children. Clinical guidelines. (Approved by the Union of Pediatricians of Russia). 2016 г. Available from: https://www.pediatr-russia.ru/information/klin-rek/deystvuyushchie-klinicheskie-rekomendatsii/ХСН%20дети%20СПР.v1.pdf. In Russian.</mixed-citation></citation-alternatives></ref><ref id="cit38"><label>38</label><citation-alternatives><mixed-citation xml:lang="ru">Руженцова Т.А., Горелов А.В. Возможности кардиометаболической терапии инфекционных миокардитов и кардиомиопатий у детей. Практика педиатра. 2012. 50-55.</mixed-citation><mixed-citation xml:lang="en">Ruzhentsova T.A., Gorelov A.V. Possibilities of cardiometabolic therapy of infectious myocarditis and cardiomyopathies in children. «Praktika pediatra».2012. с. 50-55. In Russian.</mixed-citation></citation-alternatives></ref><ref id="cit39"><label>39</label><citation-alternatives><mixed-citation xml:lang="ru">Верткин А.Л., Шишкова В.Н., Сычева А.С., Кебина А.Л., Носова А.В., Урянская К.А., Газикова Х.М., Завьялов Г.В. Возможности метаболической поддержки при коронавирусной инфекции. Терапия 2020. 7. 146-155. DOI https://dx.doi.org/10.18565/therapy.2020.7.146-155</mixed-citation><mixed-citation xml:lang="en">Vertkin A.L., Shishkova V.N., Sycheva A.S., Kebina A.L., Nosova A.V., Uryanskaya K.A., Gazikova Kh.M., Zav'yalov G.V. Possibilities of metabolic support in coronavirus infection. Terapiya №7. 2020. DOI: https://dx.DOI:.org/10.18565/therapy.2020.7.146-155. In Russian.</mixed-citation></citation-alternatives></ref><ref id="cit40"><label>40</label><citation-alternatives><mixed-citation xml:lang="ru">Перегоедова В.Н., Богомолова И.К., Бабкин А.А. Новая коронавирусная инфекция в практике врача педиатра. Забайкальский медицинский вестник. 2021. 4. 112-122. DOI: 10.52485/19986173_2021_4_112. Available from: http://zabmedvestnik.ru/arhiv-nomerov/nomer-4-za-2021-god/novaja-koronavirusnaja-infekcija-v-praktike-vracha-pediatra/1013/11.pdf.</mixed-citation><mixed-citation xml:lang="en">Peregoedova V.N., Bogomolova I.K., Babkin A.A. A new coronavirus infection in the practice of a pediatrician. Zabaykal'skiy meditsinskiy vestnik. 2021. DOI: 10.52485/19986173_2021_4_112. In Russian.</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
